Skip to main content

Avalo Therapeutics Inc (NQ: AVTX )

21.75 +17.00 (+357.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2024 Add to My Watchlist

Other Filings

Form REVOKED
Source: SEC/Edgar
August 18, 2015
Form 10-K/A
Source: SEC/Edgar
January 22, 2013
Form NT 10-K
Source: SEC/Edgar
June 28, 2011
Form 10-K/A
Source: SEC/Edgar
June 05, 2011
Form 8-K
Source: SEC/Edgar
June 05, 2011
Form NT 10-Q
Source: SEC/Edgar
February 13, 2011
Form NT 10-Q
Source: SEC/Edgar
November 14, 2010
Form NT 10-K
Source: SEC/Edgar
June 28, 2010
Form 8-K
Source: SEC/Edgar
April 20, 2010
Form 8-K
Source: SEC/Edgar
March 28, 2010
Form DEF 14C
Source: SEC/Edgar
March 07, 2010
Form DEFA14C
Source: SEC/Edgar
February 23, 2010
Form NT 10-Q
Source: SEC/Edgar
February 15, 2010
Form 8-K
Source: SEC/Edgar
February 07, 2010
Form SC 14F1
Source: SEC/Edgar
January 19, 2010
Form 8-K
Source: SEC/Edgar
January 14, 2010
Form 10-Q/A
Source: SEC/Edgar
January 05, 2010
Form 10-Q/A
Source: SEC/Edgar
January 05, 2010
Form 10-K/A
Source: SEC/Edgar
January 05, 2010
Form NT 10-K
Source: SEC/Edgar
September 28, 2009
Form 10-Q/A
Source: SEC/Edgar
January 05, 2009
Form 10-Q/A
Source: SEC/Edgar
January 05, 2009
Form NT 10-Q
Source: SEC/Edgar
November 13, 2008
Form NT 10-K
Source: SEC/Edgar
September 28, 2008
Form NT 10-Q
Source: SEC/Edgar
May 14, 2008
Form 10QSB
Source: SEC/Edgar
February 18, 2008
Form NT 10-Q
Source: SEC/Edgar
February 13, 2008
Form 8-K/A
Source: SEC/Edgar
January 16, 2008
Form 8-K
Source: SEC/Edgar
January 06, 2008
Form SC 13D
Source: SEC/Edgar
December 09, 2007
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.